16 March 2026
On-line (Zoom) and in-person, with free registration.
–> In-Person Registration Link
–> Zoom only registration
* If you plan to use both in-person and Zoom, please register using both links.
Location: Domus Medica, Auditorium L-200
Address: Sognsvannsveien 9, 0372 Oslo, Norway

Welcome message by the NO-Age/AD board members
The ageing population is growing rapidly across the Nordic countries and beyond, leading to increased healthcare and socioeconomic challenges. Ageing is the primary risk factor for many diseases, including neurodegenerative diseases such as Alzheimer’s disease (AD). Our understanding of the molecular mechanisms underlying brain ageing and neurodegeneration remains limited.

Held in Norway, the NO-Age/AD meeting series bring together leaders in the fields to explore key topics, including molecular mechanisms of ageing and dementia, multi-omics approaches, artificial intelligence applications, neurodegeneration, and translational drug development. Speakers are leaders in these fields around the world! This meeting series also strongly support young researchers by reserving space for short talks and a poster session, ensuring the next generation of scientists to play active roles in advancing the field. By facilitating interdisciplinary discussions and collaborations, we aim to drive innovation towards a future of healthy ageing and improved treatments for age-related diseases.

Organizers:
Evandro F. Fang-Stavem (Oslo, Norway)
Linda Bergersen (UiO, Norway)
Jon Storm-Mathisen (UiO, Norway)
Hilde Nilsen (UiO, Norway) Asgeir Kobro-Flatmoen (NTNU, Norway)

Program (Tentative and to be updated): 2026-03-12 version